"By Megan Brooks
Medscape Medical News
The US Food and Drug Administration (FDA) will require makers of prescription testosterone products to clarify the approved uses of these medications on the product label and add information"...
There is no known treatment to reverse the antiplatelet effect of ZONTIVITY, and neither dialysis nor platelet transfusion can be expected to be beneficial if bleeding occurs after overdose. Inhibition of platelet aggregation can be expected for weeks after discontinuation of normal dosing [see CLINICAL PHARMACOLOGY]. There is no standard test available to assess the risk of bleeding in an overdose situation.
History Of Stroke, Transient Ischemic Attack (TIA), Or Intracranial Hemorrhage (ICH)
Active Pathologic Bleeding
Last reviewed on RxList: 5/6/2015
Additional Zontivity Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.